glutathione and multiple myeloma Targeting metabolism: How abnormal metabolism contributes to myeloma progression resistance to proteasome inhibitors Frontiers | Metabolic Reprogramming Induces
Frontiers Metabolic Reprogramming Induces Immune Cell Dysfunction in the Tumor Microenvironment of Multiple Myeloma Glutathione Depletion and Stalwart Anticancer Activity of Metallotherapeutics Inducing Programmed Cell Death: Opening a New Window for Cancer Therapy ACS Omega The glutathione synthesis inhibitor buthionine sulfoximine synergistically enhanced melphalan activity against preclinical models of multiple myeloma Blood Cancer Journal Targeting Reactive Oxygen Species Metabolism to Induce Myeloma Cell Death Review on Bortezomib Resistance in Multiple Myeloma and Potential Role of Emerging Technologies
Pay in 4 interest-free payments of $6.39 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Aug 7 - Aug 12




